Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2023; 13(11):3640. doi:10.7150/thno.82877 This issue Cite

Erratum

Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

Ping Ji1*, Yongxin Zhou2*, Yibao Yang1*, Junlu Wu1, Hao Zhou3, Wenqiang Quan1, Junjun Sun1, Yiwen Yao1, Anquan Shang1, Chenzheng Gu1, Bingjie Zeng1, Jenni Firrman4, Weidong Xiao5, Robert Bals6, Zujun Sun1, Dong Li1✉

1. Department of Clinical Laboratory, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
2. Department of Thoracic-cardiovascular Surgery, Tongji hospital,Tongji University School of Medicine, Shanghai 200065, China.
3. Department of Pharmacy, Putuo People's Hospital, Shanghai 200060, China.
4. Dairy and Functional Foods Research Unit, Eastern Regional Research Center, Agriculture Research Service, United States Department of Agriculture, Wyndmoor, PA 19038, USA.
5. Sol Sherry Thrombosis Research Center, Temple University, Philadelphia, PA 19140, USA.
6. Department of Internal Medicine V-Pulmonology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital, Homburg 66424, Germany.
*The authors contributed equally to this work.

✉ Corresponding authors: Zujun Sun, email: 14111010030edu.cn; and Dong Li, email: lidongedu.cn

Citation:
Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan W, Sun J, Yao Y, Shang A, Gu C, Zeng B, Firrman J, Xiao W, Bals R, Sun Z, Li D. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics 2023; 13(11):3640. doi:10.7150/thno.82877. https://www.thno.org/v13p3640.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 9, 2209

Citation styles

APA
Ji, P., Zhou, Y., Yang, Y., Wu, J., Zhou, H., Quan, W., Sun, J., Yao, Y., Shang, A., Gu, C., Zeng, B., Firrman, J., Xiao, W., Bals, R., Sun, Z., Li, D. (2023). Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics, 13(11), 3640. https://doi.org/10.7150/thno.82877.

ACS
Ji, P.; Zhou, Y.; Yang, Y.; Wu, J.; Zhou, H.; Quan, W.; Sun, J.; Yao, Y.; Shang, A.; Gu, C.; Zeng, B.; Firrman, J.; Xiao, W.; Bals, R.; Sun, Z.; Li, D. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics 2023, 13 (11), 3640. DOI: 10.7150/thno.82877.

NLM
Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan W, Sun J, Yao Y, Shang A, Gu C, Zeng B, Firrman J, Xiao W, Bals R, Sun Z, Li D. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics 2023; 13(11):3640. doi:10.7150/thno.82877. https://www.thno.org/v13p3640.htm

CSE
Ji P, Zhou Y, Yang Y, Wu J, Zhou H, Quan W, Sun J, Yao Y, Shang A, Gu C, Zeng B, Firrman J, Xiao W, Bals R, Sun Z, Li D. 2023. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum. Theranostics. 13(11):3640.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use